Insulet Corp. (PODD)
149.83
+0.57
(+0.38%)
USD |
NASDAQ |
Oct 27, 16:00
150.00
+0.17
(+0.11%)
After-Hours: 20:00
Insulet Enterprise Value : 10.80B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 10.80B |
| October 26, 2026 | 10.76B |
| October 23, 2026 | 10.75B |
| October 22, 2026 | 10.69B |
| October 21, 2026 | 10.25B |
| October 20, 2026 | 10.31B |
| October 19, 2026 | 10.26B |
| October 16, 2026 | 10.20B |
| October 15, 2026 | 10.04B |
| October 14, 2026 | 9.702B |
| October 13, 2026 | 9.993B |
| October 12, 2026 | 10.11B |
| October 09, 2026 | 9.795B |
| October 08, 2026 | 9.739B |
| October 07, 2026 | 9.732B |
| October 06, 2026 | 9.757B |
| October 05, 2026 | 9.819B |
| October 02, 2026 | 9.546B |
| October 01, 2026 | 9.484B |
| September 30, 2026 | 9.462B |
| September 29, 2026 | 9.626B |
| September 28, 2026 | 9.645B |
| September 25, 2026 | 9.854B |
| September 24, 2026 | 9.830B |
| September 23, 2026 | 9.879B |
| Date | Value |
|---|---|
| September 22, 2026 | 10.08B |
| September 21, 2026 | 10.16B |
| September 18, 2026 | 10.16B |
| September 17, 2026 | 10.23B |
| September 16, 2026 | 10.16B |
| September 15, 2026 | 10.07B |
| September 14, 2026 | 9.970B |
| September 11, 2026 | 9.565B |
| September 10, 2026 | 9.754B |
| September 09, 2026 | 9.978B |
| September 08, 2026 | 10.28B |
| September 04, 2026 | 10.64B |
| September 03, 2026 | 10.86B |
| September 02, 2026 | 10.69B |
| September 01, 2026 | 10.70B |
| August 31, 2026 | 10.72B |
| August 28, 2026 | 10.48B |
| August 27, 2026 | 10.36B |
| August 26, 2026 | 10.36B |
| August 25, 2026 | 10.33B |
| August 24, 2026 | 10.50B |
| August 21, 2026 | 10.69B |
| August 20, 2026 | 10.60B |
| August 19, 2026 | 10.92B |
| August 18, 2026 | 10.68B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PROCEPT BioRobotics Corp. | 983.08M |
| Boston Scientific Corp. | 77.41B |
| Abbott Laboratories | 206.06B |
| DexCom, Inc. | 29.10B |
| The Cooper Cos., Inc. | 13.77B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 95.00M |
| Revenue (Quarterly) | 801.70M |
| Total Expenses (Quarterly) | 706.70M |
| EPS Diluted (Quarterly) | 1.066 |
| Gross Profit Margin (Quarterly) | 72.56% |
| Profit Margin (Quarterly) | 11.85% |
| Earnings Yield | 3.37% |
| Operating Earnings Yield | 4.90% |
| Normalized Earnings Yield | 3.306 |